Global Vascular Graft Market - Forecasts from 2018 to 2023

Global vascular graft market is projected to witness a CAGR of 6.52% over the forecast period of 2017-2023. Vascular grafts are the materials used to patch injured or diseased areas of the arteries, replacements of the damaged segments of the larger arteries such as aorta. The graft is introduced through a surgical procedure to redirect the blood flow from one part to another. The biocompatibility of the grafts coupled with the sturdiness make them ideal for enhancing the vascular access through surgeries.

Rising Prevalence of the Cardiac Diseases and Coronary Artery Diseases to Boost the Market
The growth in the market may be attributed to the rising prevalence of the cardiac diseases, coronary artery diseases, hypertension, renal diseases and cardiac aneurysms. As per data by WHO, around 17.7 million people die each year from Cardiovascular Diseases, constituted nearly 31% of the global mortality rate. Rising geriatric population will further augment the growth of the market during the forecast period. Unhealthy lifestyle and factors such as rising adoption of the smoking and drinking habits have also increased the risk of diabetes and coronary artery diseases, thereby increasing the requirements of vascular grafts and providing ample opportunities for the companies to enter the market. Advancements in graft materials and introduction of biomaterials will also significantly bolster the market growth during the forecast period. However, high procedure cost and complications associated with surgeries such as bleeding, arrhythmias and infection might restrain the vascular graft market growth during the forecast period.

North America to Dominate the Vascular Graft Market
Geographically, North America is expected to dominate the market owing to the high number of lifestyle related diseases, specifically hypertension and coronary artery diseases. According to statistics released by the American Heart Association, approximately 84 million people in the U.S. suffer from some form of cardiovascular disease, causing about 2,200 deaths a day. Presence of skilled workforce, favorable reimbursement policies and proper healthcare infrastructure will further boost the market in the region. Asia Pacific is expected to show the fastest growth owing to the rising number of patients suffering from cardiovascular diseases and improving healthcare facilities in the region.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global vascular grafts market.

Major industry players profiled as part of the report are Hancock Jaffe Laboratories, Inc., W. L. Gore & Associates and Vascular Genesis among others.

Segmentation

By Source

Synthetic
Semi Synthetic
Natural

By Indication

Cardiovascular Diseases
Renal Diseases
Aneurysms
Others

By End-User

Hospitals
Ambulatory Surgical Centres

By Geography

North America

United States
Canada
Others

South America

Brazil
Argentina
Others

Europe

United Kingdom
Germany
France
Others

Middle East and Africa

Israel
Saudi Arabia
UAE
Others

Asia Pacific

China
India
Australia
South Korea
Others